The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for PT Prodia Widyahusada Tbk's 9-Day RSI or its related term are showing as below:
ISX:PRDA's 9-Day RSI is ranked better than 54.79% of 219
companies
in the Medical Diagnostics & Research industry
Industry Median: 54.03
vs ISX:PRDA: 58.70
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
PT Prodia Widyahusada Tbk 9-Day RSI Related Terms
ISX:PRDA vs TMO, DHR, IDXX: 9-Day RSI Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk 9-Day RSI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (ISX:PRDA) has a 9-Day RSI of 58.70 as of Jul. 06, 2026. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #99 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 45.2%.
Is PT Prodia Widyahusada Tbk's 9-Day RSI too high?
PT Prodia Widyahusada Tbk's current 9-Day RSI is 58.70. The Medical Diagnostics & Research industry median 9-Day RSI is 54.03. PT Prodia Widyahusada Tbk's value of 58.70 is 8.6% above this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #99 out of 219 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's 9-Day RSI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #99 out of 219 companies for 9-Day RSI. This puts PT Prodia Widyahusada Tbk in the upper half of its industry. The industry median 9-Day RSI is 54.03. PT Prodia Widyahusada Tbk's value of 58.70 is 8.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Diagnostics & Research company?
The median 9-Day RSI among Medical Diagnostics & Research companies is 54.03, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current 9-Day RSI of 58.70 is 8.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median 9-Day RSI is 54.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current 9-Day RSI is 58.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,128.92, compared to a current price of Rp2,580.00 — trading 17.5% below its estimated fair value. The current 9-Day RSI is 58.70 and 8.6% above the Medical Diagnostics & Research industry median of 54.03. PT Prodia Widyahusada Tbk's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current 9-Day RSI is 58.70 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued.
The current stock price of Rp2,580.00 is trading 17.5% below its estimated GF Value™ of Rp3,128.92.
GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRDA:
9-Day RSI: 58.70
GF Value™: Rp3,128.92 vs. price of Rp2,580.00 (17.5% below fair value)
Industry Position: 8.6% above the Medical Diagnostics & Research median (#99 of 219)
No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
69GF Score
Get the complete analysis for ISX:PRDA
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRDA has been successfully added to your 